Zahler, D.; Arnold, J.H.; Bar-On, T.; Raphael, A.; Khoury, S.; Rozenbaum, Z.; Banai, S.; Arbel, Y.; Topilsky, Y.; Laufer-Perl, M.
Valvular Heart Disease following Anthracycline Therapy—Is It Time to Look beyond Ejection Fraction? Life 2022, 12, 1275.
https://doi.org/10.3390/life12081275
AMA Style
Zahler D, Arnold JH, Bar-On T, Raphael A, Khoury S, Rozenbaum Z, Banai S, Arbel Y, Topilsky Y, Laufer-Perl M.
Valvular Heart Disease following Anthracycline Therapy—Is It Time to Look beyond Ejection Fraction? Life. 2022; 12(8):1275.
https://doi.org/10.3390/life12081275
Chicago/Turabian Style
Zahler, David, Joshua H. Arnold, Tali Bar-On, Ari Raphael, Shafik Khoury, Zach Rozenbaum, Shmuel Banai, Yaron Arbel, Yan Topilsky, and Michal Laufer-Perl.
2022. "Valvular Heart Disease following Anthracycline Therapy—Is It Time to Look beyond Ejection Fraction?" Life 12, no. 8: 1275.
https://doi.org/10.3390/life12081275
APA Style
Zahler, D., Arnold, J. H., Bar-On, T., Raphael, A., Khoury, S., Rozenbaum, Z., Banai, S., Arbel, Y., Topilsky, Y., & Laufer-Perl, M.
(2022). Valvular Heart Disease following Anthracycline Therapy—Is It Time to Look beyond Ejection Fraction? Life, 12(8), 1275.
https://doi.org/10.3390/life12081275